| Literature DB >> 29184398 |
Samantha L Harrison1, Annemarie L Lee2,3,4, Helene L Elliott-Button1, Rebecca Shea5, Roger S Goldstein2,3,6, Dina Brooks2,3, Cormac G Ryan1, Denis J Martin1.
Abstract
INTRODUCTION: One third of individuals with chronic obstructive pulmonary disease (COPD) report pain. To help inform a COPD-specific pain intervention, we explored the views of health care providers (HCPs) and individuals with COPD on pain during pulmonary rehabilitation (PR).Entities:
Keywords: COPD; education; health care professions; pain; pulmonary rehabilitation; qualitative
Mesh:
Year: 2017 PMID: 29184398 PMCID: PMC5685149 DOI: 10.2147/COPD.S145442
Source DB: PubMed Journal: Int J Chron Obstruct Pulmon Dis ISSN: 1176-9106
Figure 1Recruitment flow diagram.
Abbreviations: COPD, chronic obstructive pulmonary disease; HCP, health care provider.
Demographics of HCPs
| HCP ID, site | Age (y) | Sex | Profession | Experience delivering PR (y) |
|---|---|---|---|---|
| 1 UK | 48 | F | Physiotherapy assistant | 1.5 |
| 2 UK | 29 | F | Physiotherapy assistant | 6 |
| 3 UK | 34 | F | Specialist physiotherapist | 6 |
| 4 UK | 47 | F | Physiotherapy assistant | 1 |
| 5 UK | 38 | F | Physiotherapist | 1.5 |
| 6 UK | 29 | F | Physiotherapist | 1 |
| 7 UK | 31 | F | Physiotherapist | 1.5 |
| 1 Canada | 26 | F | Physiotherapist | 3.5 |
| 2 Canada | 48 | F | Physiotherapist | 15 |
| 3 Canada | 26 | M | Physiotherapist | 1 |
| 4 Canada | 35 | F | Nurse | 6 |
| 5 Canada | 41 | F | Nurse | 3 |
| 6 Canada | 65 | M | Respiratory physician | 30 |
| 7 Canada | 73 | F | Respiratory physician | 35 |
| 8 Canada | 32 | F | Physiotherapy assistant | 0.5 |
| 9 Canada | 41 | F | Occupational therapist | 10 |
| 10 Canada | 50 | F | Occupational therapist | 15 |
| 11 Canada | 33 | M | Physiotherapist | 4 |
Abbreviations: M, male; F, female; HCP, health care provider; y, years.
Demographics of individuals with COPD
| Patient ID, site | Age (years) | Sex | BMI (kg/m2) | Social status | FEV1 (L) | FEV1/FVC (%) | Disease duration (years) | Comorbidities (n) | Systems affected | Smoking status | Pack-years | Hospitalizations in previous 12 months (n) | Oxygen therapy | Walking aid |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 UK | 77 | M | 26.8 | Alone | 1.71 | 56 | 6 | 5 | Cardiac, MSK | Ex | 60 | 0 | No | No |
| 2 UK | 59 | M | 29.7 | Spouse/family | 1.41 | 54 | 6 | 4 | MSK, mental, ENT | Current | 92 | 1 | No | No |
| 3 UK | 72 | M | 18.2 | Alone | 1.65 | 50 | 6 | 7 | Cardiac, MSK, reproductive, skin | Ex | 44 | 1 | No | Yes |
| 4 UK | 66 | F | 22 | Alone | 0.9 | 45 | 16 | 9 | Respiratory, circulatory, MSK, muscular, mental | Ex | 43 | 2 | No | Yes |
| 5 UK | 69 | F | 15.5 | Spouse | 1.12 | 63 | 2 | 1 | MSK | Current | 108 | 0 | No | No |
| 6 UK | 63 | M | 29 | Spouse/family | 2.7 | 60 | 10 | 10 | Cardiac, respiratory, MSK, mental | Ex | 86 | 2 | No | Yes |
| 7 UK | 68 | F | 32 | Alone | 0.75 | 41 | 13 | 6 | Respiratory, MSK, mental, circulatory | Ex | 43 | 0 | No | Yes |
| 8 UK | 66 | F | 12.8 | Spouse | 0.62 | 65 | 3 | 9 | Respiratory, MSK, digestive, muscular, mental | Ex | 70 | 0 | Yes | No |
| 9 UK | 64 | F | 29.9 | Spouse | 0.71 | 61 | 11 | 2 | Respiratory, mental | Current | 47 | 1 | No | No |
| 1 Canada | 67 | F | 47.7 | Friend | 0.81 | 40 | 6 | 4 | Circulatory, endocrine, urinary | Ex | 55 | 0 | Yes | Yes |
| 2 Canada | 82 | F | 34.2 | Family | 0.7 | 52 | 6 | 8 | Cardiac, MSK, urinary, mental, circulatory | Current | 100 | 4 | Yes | Yes |
| 3 Canada | 58 | F | 49.4 | Family | 0.53 | 44 | 13 | 5 | Circulatory, respiratory, MSK, mental | Ex | 57 | 3 | Yes | Yes |
| 4 Canada | 68 | M | 28.9 | Spouse | 1.48 | 33 | 11 | 3 | MSK, digestive | Ex | 50 | 0 | No | No |
| 5 Canada | 67 | M | 44.3 | Alone | 1.95 | 59 | 9 | 0 | Not applicable | Ex | 30 | 0 | No | No |
| 6 Canada | 52 | M | 26.5 | Alone | 0.92 | 46 | 5 | 5 | Respiratory, skeletal, MSK | Ex | 6 | 0 | Yes | No |
| 7 Canada | 73 | F | 28.7 | Family | 0.64 | 49 | 6 | 6 | Respiratory, circulatory, mental | Ex | 80 | 1 | Yes | Yes |
| 8 Canada | 56 | F | 30.5 | Alone | 0.56 | 31 | 15 | 5 | Cardiac, circulatory, digestive, mental, MSK | Ex | 43 | 0 | Yes | Yes |
| 9 Canada | 66 | F | 27.3 | Spouse | 0.37 | 21 | 11 | 7 | Respiratory, circulatory, skeletal, digestive, mental, MSK | Ex | 35 | 2 | Yes | Yes |
| 10 Canada | 69 | F | 21.1 | Alone | 0.81 | 39 | 7 | 5 | Respiratory, MSK, mental, ENT | Ex | 55 | 0 | No | Yes |
Abbreviations: COPD, chronic obstructive pulmonary disease; BMI, body mass index; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; MSK, musculoskeletal; ENT, ear, nose, and throat; M, male; F, female.
Pain-related information of individuals with COPD
| Patient ID, site | Pain duration (years) | Pain frequency | Pain medications and dose | BPI pain severity (mean) | BPI pain interference (mean) |
|---|---|---|---|---|---|
| 1 UK | >10 | At least once a day | Paracetamol 2×500 mg daily | 2.25 | 1.29 |
| 2 UK | 5–10 | Constant | Co-codamol 2×500 mg twice daily | 2.50 | 1.57 |
| 3 UK | >10 | Constant | Paracetamol 2×500 mg twice daily | 4.75 | 5.71 |
| 4 UK | >10 | Constant | Paracetamol 500 mg prn, co-codamol 500 mg prn | 3.75 | 5 |
| 5 UK | >10 | At least once a day | Co-codamol 3×500 mg daily | 3.00 | 1.29 |
| 6 UK | 5–10 | At least once a day | Co-drydamol 500 mg prn | 3.00 | 4.86 |
| 7 UK | >10 | Constant | Co-codamol 500 mg prn | 3.50 | 1.14 |
| 8 UK | 5–10 | At least once a day | Paracetamol 500 mg prn, co-codamol 500 mg prn | 4.50 | 3.29 |
| 9 UK | >10 | At least once a day | Codeine phosphate 2×30 mg daily, paracetamol 500 mg prn | 4.75 | 5.86 |
| 1 Canada | 1–3 | Constant | Tylenol extra strength daily 1 daily | 4.75 | 2.14 |
| 2 Canada | 1 | Constant | Diclofenac, Voltaren emulgel prn | 2.75 | 0.86 |
| 3 Canada | >10 | Constant | Hydromorphone slow, hydromorphone, ibuprofen prn | 3.00 | 5.00 |
| 4 Canada | >10 | Constant | Naproxen 500 mg prn | 2.75 | 0.71 |
| 5 Canada | <1 | At least once a day | Tylenol prn | 1.50 | 1.00 |
| 6 Canada | >10 | Constant | Tylenol 1×100 mg daily, gabapentin 1×100 mg daily | 3.75 | 6.57 |
| 7 Canada | 5 | Constant | Tylenol 650 mg prn | 1.00 | 4.57 |
| 8 Canada | >10 | At least once a day | Oxycodone 2×40 mg twice daily | 6.00 | 4.41 |
| 9 Canada | >10 | Constant | Tylenol 2×40 mg twice daily | 6.00 | 6.14 |
| 10 Canada | 3–4 | At least once a day | Ibuprofen 200 mg prn | 4.50 | 1.14 |
Abbreviations: COPD, chronic obstructive pulmonary disease; prn, pro re nata/as required; BPI, Brief Pain Inventory (Short Form).